Hepatic veno-occlusive disease following bone marrow transplantation
Grandt, N.C.
Oncology Nursing Forum 16(6): 813-817
1989
ISSN/ISBN: 0190-535X PMID: 2687804 Document Number: 342465
More than 2,000 bone marrow transplants (BMT) are performed in the United States each year. Hepatic veno-occlusive disease is a relatively frequent complication of BMT, occurring in up to 21% of patients treated with chemotherapy for malignant conditions. This potentially serious complication can have a major impact on the treatment and care of these patients. Knowledge of the pathophysiology, clinical features, and risk factors of this disease can assist nurses with early detection, management, support, and education for the patient and family.
Document emailed within 1 workday
Related Documents
Salat, C.; Holler, E.; Hiller, E.; Pihusch, R.; Kolb, H.J. 1999: Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation Haematologica 84 Suppl Eha-4: 40-43Gluckman, E.; Jolivet, I.; Scrobohaci, M.L.; Devergie, A.; Traineau, R.; Bourdeau-Espérou, H.; Lehn, P.; Faure, P.; Drouet, L. 1990: Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 32(1): 1-3
Or, R.; Nagler, A.; Shpilberg, O.; Elad, S.; Naparstek, E.; Kapelushnik, J.; Cass, Y.; Gillis, S.; Chetrit, A.; Slavin, S.; Eldor, A. 1996: Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients Transplantation 61(7): 1067-1071
Rio, B.; Zittoun, R.; Ifrah, N.; Aubert, J.; Pene, F. 1984: Incidence and severity of veno-occlusive diseases of the liver after bone marrow transplantation Presse Medicale 13(43): 2648
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Bane, A. 2008: Hepatic veno-occlusive disease Ethiopian Medical Journal 46(1): 105-108
Ghanem, J.; Hershko, C. 1981: Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs Israel Journal of Medical Sciences 17(5): 339-347
Wu, G-Lin.; Yu, G-You.; Chen, J. 2008: Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon Zhongguo Zhong Yao Za Zhi 33(20): 2402-2404
Espigado, I.; Rodríguez, J.M.; Parody, R.; Carmona, M.; Digón, J.; Olloqui, E. 1995: Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment Bone Marrow Transplantation 16(2): 313-316
Goldberg, S.L.; Shubert, J.; Rao, A.K.; Redei, I.; Klumpp, T.R.; Mangan, K.F. 1996: Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile Bone Marrow Transplantation 18(3): 633-636
Liew, C.T. 1990: A comparative histopathological study of hepatic venous outflow obstruction in veno-occlusive disease and Budd-Chiari's syndrome Changgeng Yi Xue Za Zhi 13(3): 167-181
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
Azoulay, D.; Castaing, D.; Lemoine, A.; Samuel, D.; Majno, P.; Reynes, M.; Charpentier, B.; Bismuth, H. 1998: Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt Clinical Nephrology 50(2): 118-122
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Gassmann, W.; von Kolszynski, M.; Wottge, H.U.; Müller-Ruchholtz, W. 1987: Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation Transplantation Proceedings 19(1 Part 3): 2687-2688
León-Rodríguez, E.; Sosa Sánchez, R.; Gómez, E.; Ochoa Sosa, C. 1993: Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 45(6): 559-564
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470